Pompe Disease in Babies
Medically reviewed by Dr. Michael Okonkwo, MD, FAAP · Board-Certified Neonatologist
Content reviewed against published NIH, HRSA, ACMG guidelines
Last reviewed:
If your baby has been diagnosed with or you suspect pompe disease in babies, here is what the evidence says.
The short answer
Pompe disease (glycogen storage disease type II) is a rare inherited disorder where the body cannot break down glycogen properly, causing it to build up in muscles. The infantile-onset form is the most severe, presenting in the first months of life with a dangerously enlarged heart (cardiomyopathy), significant muscle weakness (floppy baby), and breathing and feeding difficulties. Pompe disease is on the federal Recommended Uniform Screening Panel (RUSP), so most babies in the United States are screened at birth. Enzyme replacement therapy with alglucosidase alfa has dramatically improved outcomes when started early.
Key takeaways
- Pompe disease (glycogen storage disease type II) is a rare inherited disorder where the body cannot break down glycogen properly, causing it to build up in muscles. The infantile-onset form is the most severe, presenting in the first months of life with a dangerously enlarged heart (cardiomyopathy), significant muscle weakness (floppy baby), and breathing and feeding difficulties. Pompe disease is on the federal Recommended Uniform Screening Panel (RUSP), so most babies in the United States are screened at birth. Enzyme replacement therapy with alglucosidase alfa has dramatically improved outcomes when started early.
- Usually normal when: Your baby's newborn screening came back normal for Pompe disease
- Call your doctor if: Your newborn has screened positive for Pompe disease — confirmatory testing should be arranged urgently because early treatment is critical for outcomes
- Varies by age — see the age-by-age breakdown below
“Fever itself is not an illness — rather, it is a sign or symptom that the body is fighting an infection. Fever stimulates certain defenses, such as the white blood cells, which attack and destroy invading bacteria.”
Parents everywhere have the same worry. You are doing the right thing by looking into it.
What Parents Should Know
According to NIH, HRSA, ACMG guidelines, pompe disease (glycogen storage disease type II) is a rare inherited disorder where the body cannot break down glycogen properly, causing it to build up in muscles. The infantile-onset form is the most severe, presenting in the first months of life with a dangerously enlarged heart (cardiomyopathy), significant muscle weakness (floppy baby), and breathing and feeding difficulties. Pompe disease is on the federal Recommended Uniform Screening Panel (RUSP), so most babies in the United States are screened at birth. Enzyme replacement therapy with alglucosidase alfa has dramatically improved outcomes when started early. At 0-1 month, babies with infantile-onset Pompe disease may appear normal at birth, but symptoms often develop rapidly in the first weeks of life. A chest X-ray or echocardiogram may reveal a massively enlarged heart (hypertrophic cardiomyopathy), which is the hallmark of infantile Pompe disease. Newborn screening detects the enzyme deficiency before symptoms develop, allowing immediate treatment. If your baby's newborn screen is positive for Pompe disease, confirmatory testing (enzyme activity and genetic testing) will be done urgently. It is generally considered normal when your baby's newborn screening came back normal for Pompe disease. However, you should contact your pediatrician promptly if your newborn has screened positive for Pompe disease — confirmatory testing should be arranged urgently because early treatment is critical for outcomes.
Normal vs. Concerning
When to Seek Immediate Care
- Your newborn has screened positive for Pompe disease — confirmatory testing should be arranged urgently because early treatment is critical for outcomes
- Your baby has a rapidly enlarging heart, severe muscle weakness, and difficulty breathing — these signs need immediate cardiac and metabolic evaluation
- Your baby with known Pompe disease develops signs of heart failure such as rapid breathing, poor feeding, excessive sweating during feeds, or blue-tinged lips
- Your baby is extremely floppy, cannot lift their head at all, and has labored breathing — seek emergency evaluation
By Age
What to expect by age
0-1 month
Babies with infantile-onset Pompe disease may appear normal at birth, but symptoms often develop rapidly in the first weeks of life. A chest X-ray or echocardiogram may reveal a massively enlarged heart (hypertrophic cardiomyopathy), which is the hallmark of infantile Pompe disease. Newborn screening detects the enzyme deficiency before symptoms develop, allowing immediate treatment. If your baby's newborn screen is positive for Pompe disease, confirmatory testing (enzyme activity and genetic testing) will be done urgently.
1-3 months
Without treatment, babies with infantile Pompe disease develop progressive muscle weakness — they feel floppy when picked up, have poor head control, and may have difficulty feeding. Breathing becomes labored because both the diaphragm and chest muscles are weakened. The heart continues to enlarge, which can lead to heart failure. Enzyme replacement therapy (ERT) with alglucosidase alfa, started in the first weeks of life, has been shown to dramatically reduce heart size and improve survival. Babies on ERT still need close cardiology and pulmonology monitoring.
3-6 months
Babies diagnosed and started on ERT early often show significant improvement in heart size and function within the first few months of treatment. Motor development may be delayed compared to peers, but many babies on early treatment achieve milestones like head control and rolling. Physical therapy is an important part of care. Some babies develop antibodies against the replacement enzyme, which can reduce treatment effectiveness — your metabolic team will monitor for this.
6-12 months
With early and ongoing ERT, many babies with infantile Pompe disease show continued motor progress, though they often remain behind their peers in gross motor skills. Regular echocardiograms monitor heart size and function. Hearing should be monitored, as some children with Pompe disease develop hearing loss. Respiratory function is followed closely, and some children may need breathing support during sleep. Dietary support and speech therapy may be needed for feeding difficulties.
1 year and beyond
Long-term management of Pompe disease involves biweekly ERT infusions, regular cardiology and pulmonology follow-up, and ongoing physical and occupational therapy. Newer enzyme therapies (avalglucosidase alfa) may offer improved muscle uptake. Gene therapy clinical trials are underway and represent a potential future cure. Children with late-onset Pompe disease (which presents later in childhood or adulthood) have milder symptoms primarily affecting skeletal muscles, without the severe cardiomyopathy seen in infantile Pompe.
What to Tell Your Pediatrician
- Describe when you first noticed pompe disease in babies and how it has changed over time.
- Note your baby's current age and which age-specific patterns you are seeing.
- Mention if your baby received an abnormal Pompe disease result on newborn screening — follow up promptly for confirmatory testing.
- Mention if your baby seems unusually floppy or weak and is having difficulty with feeding or breathing.
- Let your doctor know if you have noticed any related concerns, such as changes in feeding, sleep, or movement patterns.
- Bring a list of any questions or observations you want to discuss at the appointment.
What Should You Do?
When to take action
- Your baby's newborn screening came back normal for Pompe disease
- An initial positive screen was followed by confirmatory testing that showed normal enzyme levels — false positives occur, particularly with pseudodeficiency alleles
- Your baby with Pompe disease is on enzyme replacement therapy and their heart size is stable or decreasing, with improving motor function
- Your baby has a mild heart murmur that has been evaluated and is not related to cardiomyopathy
- Your baby received an abnormal Pompe disease result on newborn screening — follow up promptly for confirmatory testing
- Your baby seems unusually floppy or weak and is having difficulty with feeding or breathing
- Your baby on Pompe treatment seems to be plateauing or regressing in motor skills despite therapy
- There is a family history of Pompe disease and you want testing for your baby
- Your newborn has screened positive for Pompe disease — confirmatory testing should be arranged urgently because early treatment is critical for outcomes
- Your baby has a rapidly enlarging heart, severe muscle weakness, and difficulty breathing — these signs need immediate cardiac and metabolic evaluation
- Your baby with known Pompe disease develops signs of heart failure such as rapid breathing, poor feeding, excessive sweating during feeds, or blue-tinged lips
- Your baby is extremely floppy, cannot lift their head at all, and has labored breathing — seek emergency evaluation
What You Can Do at Home
- Keep track of when you notice pompe disease in babies — noting the time of day, duration, and any triggers can help your pediatrician.
- Remember that your baby's newborn screening came back normal for Pompe disease — this is generally within the range of normal.
- At 0-1 month, focus on observation rather than intervention unless your pediatrician advises otherwise.
- Follow any care instructions from your pediatrician. Keep a written log of symptoms to bring to appointments.
- While monitoring at home, seek immediate care if your newborn has screened positive for Pompe disease — confirmatory testing should be arranged urgently because early treatment is critical for outcomes.
Related Conditions
Abnormal Newborn Screening Results
An abnormal or positive newborn screening result means that further testing is needed, not that your baby definitely has a condition. Most positive screens turn out to be false positives after confirmatory testing. Newborn screening tests are intentionally sensitive to avoid missing any affected babies, so follow-up testing is essential to determine whether the result is a true positive.
My Baby Seems Floppy (Hypotonia)
A "floppy" baby is one whose muscles feel unusually relaxed and who may slip through your hands when you lift them under the arms. Many cases of mild floppiness improve on their own as your baby grows stronger, but it is important to have your pediatrician evaluate your baby to rule out any underlying conditions.
Related Resources
Frequently asked questions
Is pompe disease in babies normal?
When should I call the doctor about pompe disease in babies?
When is pompe disease in babies normal?
What causes pompe disease in babies?
What should I mention to my pediatrician about pompe disease in babies?
Is pompe disease in babies normal at 0-1 month?
Is pompe disease in babies normal at 1-3 months?
Should I go to the ER for pompe disease in babies?
Does pompe disease in babies go away on its own?
References
- [1]National Library of Medicine. Pompe Disease. MedlinePlus Genetics, 2023. NIH
- [2]Health Resources and Services Administration. Pompe Disease Fact Sheet. Baby's First Test, 2023. HRSA
- [3]American College of Medical Genetics. Pompe Disease Newborn Screening Working Group: Evidence-based Guidelines. ACMG, 2017. ACMG
Doctor Visit Checklist
Bring this checklist to your next pediatrician visit to discuss Pompe Disease in Babies.
Things to mention
- Describe when you first noticed pompe disease in babies and how it has changed over time.
- Note your baby's current age and which age-specific patterns you are seeing.
- Mention if your baby received an abnormal Pompe disease result on newborn screening — follow up promptly for confirmatory testing.
- Mention if your baby seems unusually floppy or weak and is having difficulty with feeding or breathing.
- Let your doctor know if you have noticed any related concerns, such as changes in feeding, sleep, or movement patterns.
- Bring a list of any questions or observations you want to discuss at the appointment.
Observations to share
- Your baby received an abnormal Pompe disease result on newborn screening — follow up promptly for confirmatory testing
- Your baby seems unusually floppy or weak and is having difficulty with feeding or breathing
- Your baby on Pompe treatment seems to be plateauing or regressing in motor skills despite therapy
Urgent signs to report immediately
- Your newborn has screened positive for Pompe disease — confirmatory testing should be arranged urgently because early treatment is critical for outcomes
- Your baby has a rapidly enlarging heart, severe muscle weakness, and difficulty breathing — these signs need immediate cardiac and metabolic evaluation
- Your baby with known Pompe disease develops signs of heart failure such as rapid breathing, poor feeding, excessive sweating during feeds, or blue-tinged lips
My notes
From ismybabyalright.com — free, evidence-based baby health guides
All content follows our editorial policy and is reviewed against published clinical guidelines.
2,705 evidence-based guides6 authoritative medical sources5 medical advisory board members
Related Resources
Bottom line
Most cases of pompe disease in babies are normal. Talk to your pediatrician if your newborn has screened positive for pompe disease — confirmatory testing should be arranged urgently because early treatment is critical for outcomes.
Trust your instincts. If something feels wrong, reach out to your pediatrician. Worrying about your baby means you care — that is a good thing.
Was this page helpful?
Related Medical Concerns
Abnormal Newborn Screening Results
An abnormal or positive newborn screening result means that further testing is needed, not that your baby definitely has a condition. Most positive screens turn out to be false positives after confirmatory testing. Newborn screening tests are intentionally sensitive to avoid missing any affected babies, so follow-up testing is essential to determine whether the result is a true positive.
My Baby Seems Floppy (Hypotonia)
A "floppy" baby is one whose muscles feel unusually relaxed and who may slip through your hands when you lift them under the arms. Many cases of mild floppiness improve on their own as your baby grows stronger, but it is important to have your pediatrician evaluate your baby to rule out any underlying conditions.
My Baby's Head Shape Looks Abnormal
Many babies develop temporary head shape irregularities that are completely normal. A cone-shaped head from vaginal delivery reshapes within days. Mild positional flattening (plagiocephaly) from sleeping on the back is very common and usually improves with repositioning and tummy time. However, head shape changes involving ridges, a persistently bulging fontanelle, or rapid head growth changes should be evaluated to rule out craniosynostosis.
Achondroplasia (Dwarfism) in Babies
Achondroplasia is the most common form of short-limbed dwarfism, affecting about 1 in 15,000 to 40,000 births. It is caused by a mutation in the FGFR3 gene and is usually apparent at birth with characteristic features including short limbs, a larger head, and a prominent forehead. Intelligence is normal. With monitoring for specific complications and supportive care, children with achondroplasia lead full, active, and independent lives.
Adenoid Hypertrophy and Breathing
Adenoids are lymphoid tissue located behind the nose that help fight infection in young children. When adenoids become enlarged (adenoid hypertrophy), they can block the nasal airway, causing chronic mouth breathing, snoring, nasal speech, and sleep-disordered breathing. Enlarged adenoids are most common between ages 2-7 and are a leading cause of obstructive sleep apnea in young children. Treatment ranges from watchful waiting and nasal steroids to surgical removal (adenoidectomy) if breathing or sleep is significantly affected.
Adrenoleukodystrophy (ALD) in Babies
X-linked adrenoleukodystrophy (X-ALD) is a genetic disorder affecting about 1 in 17,000 newborns, caused by mutations in the ABCD1 gene on the X chromosome. It primarily affects boys and impairs the breakdown of very long-chain fatty acids (VLCFAs), which accumulate and damage the myelin sheath in the brain and the adrenal glands. The most severe form, cerebral ALD, typically affects boys between ages 4-10 with rapid neurological decline. Newborn screening now enables early detection, and hematopoietic stem cell transplant or gene therapy performed before significant brain involvement can be life-saving.